What Shockwave Therapy Is
Extracorporeal shockwave therapy, commonly referred to as ESWT or simply shockwave therapy, is a non-invasive treatment that delivers focused acoustic pressure waves to injured or dysfunctional tissue. The technology was originally developed in the 1980s for breaking up kidney stones without surgery, and its application in musculoskeletal medicine has expanded significantly over the past two decades.
During a treatment session, a handheld applicator is placed against the skin over the target area. The device delivers rapid pulses of acoustic energy that penetrate into the underlying tissue. These pressure waves stimulate several biological responses at the cellular level: they increase local blood flow, promote the formation of new blood vessels in chronically underserved tissue, activate the body's natural inflammatory and repair cascade, and break down calcified deposits and scar tissue adhesions that contribute to pain and restricted movement.
A typical session lasts between 10 and 20 minutes depending on the area being treated. Most treatment protocols involve a series of sessions, usually between three and six, spaced one to two weeks apart. The procedure is performed in the office without anesthesia, does not require any incisions, and patients return to their normal activities immediately afterward. Some patients experience mild soreness or redness at the treatment site for a day or two following each session, which resolves on its own.
What Conditions It Treats
Shockwave therapy is most effective for chronic soft tissue conditions that involve tendons, fascia, and connective tissue. These are conditions where the tissue has failed to heal properly on its own, often because the area has poor blood supply or because the injury has shifted from an acute inflammatory phase into a degenerative one where the body is no longer actively attempting to repair the damage.
The most well-studied applications include plantar fasciitis, Achilles tendinopathy, lateral epicondylitis (tennis elbow), calcific tendinitis of the shoulder, and patellar tendinopathy. Published clinical data on plantar fasciitis in particular has been strong. Multiple randomized controlled trials have demonstrated significant pain reduction and functional improvement in patients who had previously failed conservative treatments including rest, orthotics, physical therapy, and cortisone injections.
Shockwave therapy is also used for peripheral neuropathy, myofascial trigger points, chronic muscle tightness, and certain types of non-healing soft tissue injuries. In neuropathy patients, the acoustic energy promotes increased blood flow and nerve regeneration in areas where nerve function has deteriorated, and it is frequently incorporated into comprehensive neuropathy treatment protocols alongside electrical stimulation, rehabilitation, and other conservative modalities. It is not indicated for acute injuries, fractures, areas with active infection, or conditions involving major nerve or vascular structures. It is also not a replacement for surgical intervention when surgery is clearly indicated. Its value is in the space between conservative therapies that have been exhausted and procedures that may not yet be warranted.
What the Evidence Shows
The clinical evidence for shockwave therapy varies by condition, which is important for patients to understand. For plantar fasciitis and calcific shoulder tendinitis, the evidence base is robust. Systematic reviews and meta-analyses have consistently shown statistically significant improvements in pain scores and functional outcomes compared to placebo, particularly in patients who had failed at least six months of conservative treatment.
For other tendinopathies including lateral epicondylitis and Achilles tendinopathy, the evidence is positive but more variable. Some studies show strong results while others show modest improvement over sham treatment. The variability is partly explained by differences in shockwave devices (focused versus radial), energy settings, number of sessions, and patient selection criteria across studies.
What the literature consistently supports is that shockwave therapy works best when it is used for the right condition in the right patient at the right time. It is not a universal solution for all pain, and the patients who benefit most are those with a confirmed soft tissue pathology that has failed to respond to adequate conservative care. When those criteria are met, shockwave therapy offers a genuine non-invasive option that can produce meaningful and lasting improvement without medication, injection, or surgery.
Where Shockwave Fits in Our Treatment Approach
At Frontier Pain Relief, shockwave therapy is one component of a conservative treatment toolkit that also includes chiropractic care, physical rehabilitation, class IV laser therapy, and other non-invasive modalities. It sits early in the treatment continuum, well before injections or interventional procedures, and is often used alongside rehabilitation rather than as a standalone therapy.
The decision to incorporate shockwave therapy into a patient's care plan is based on the specific diagnosis, the chronicity of the condition, and what has already been tried. For a patient with chronic plantar fasciitis who has been through orthotics, stretching protocols, and rest without improvement, shockwave therapy is a logical next step before considering a cortisone injection or a surgical consultation. For a patient with an acute muscle strain from last week, it would not be appropriate.
This is the approach we take with every modality we offer. The goal is to match the treatment to the condition and to the patient, not to apply the same protocol to everyone who walks through the door. If you are dealing with a chronic soft tissue condition that has not responded to the treatments you have tried, an evaluation can help determine whether shockwave therapy is a reasonable option for your situation.
